ArticleCancer research2025

Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.

Sana M Arnouk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.